Takumi Nakada
Overview
Explore the profile of Takumi Nakada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iihara H, Shimokawa M, Bando H, Niwa Y, Mizuno Y, Kawaguchi Y, et al.
J Cancer
. 2023 Oct;
14(14):2644-2654.
PMID: 37779870
Trastuzumab deruxtecan is classified as an anticancer agent that poses a moderate emetic risk in the international guidelines for antiemetic therapy. The guidelines recommend emesis prophylaxis using a two-drug combination...
2.
Futamura M, Ishihara K, Nagao Y, Ogiso A, Niwa Y, Nakada T, et al.
Breast Cancer
. 2023 Jan;
30(2):293-301.
PMID: 36609911
Background: Nanoparticle albumin-bound paclitaxel (nab-PTX) is a promising antibody partner for anti-human epidermal growth factor receptor 2 (HER2). We performed neoadjuvant chemotherapy (NAC) for HER2-positive breast cancer (BC) using nab-PTX...
3.
Nakada T, Hosono Y
Gan To Kagaku Ryoho
. 2018 Nov;
45(10):1504-1506.
PMID: 30382059
We investigated neoadjuvant chemotherapy for patients with human epidermal growth factor receptor 2(HER2)-positive breast cancer. Twenty-eight patients with HER2-positive breast cancer received neoadjuvant chemotherapy from January 2011 to December 2017....
4.
Toyama T, Yoshimura A, Hayashi T, Kobayashi N, Saito K, Tsuneizumi M, et al.
Breast Cancer
. 2018 Jun;
25(6):729-735.
PMID: 29948956
Background: Pyridoxine, an activated form of vitamin B6 used to treat allergic dermatitis, may prevent capecitabine-associated hand-foot syndrome (HFS), although evidence of the benefit of prophylactic pyridoxine is lacking. The...
5.
Tanaka K, Hori A, Tachi T, Osawa T, Nagaya K, Makino T, et al.
J Pharm Health Care Sci
. 2018 May;
4:9.
PMID: 29736254
Background: In recent years, cancer chemotherapy is being conducted at outpatient clinics, wherein pharmacists are involved with patient guidance and management of adverse events as experts in medication therapy. Therefore,...
6.
Futamura M, Nagao Y, Ishihara K, Takeuchi M, Nakada T, Kawaguchi Y, et al.
Breast Cancer
. 2017 Jan;
24(4):615-623.
PMID: 28050738
Background: Recently, the use of taxane-based regimens before anthracycline-based regimens has been shown to achieve high pathological complete response (pCR) rates in patients with breast cancer. Nanoparticle albumin-bound paclitaxel (nab-PTX)...
7.
Tachi T, Teramachi H, Tanaka K, Asano S, Osawa T, Kawashima A, et al.
Springerplus
. 2016 Apr;
5:327.
PMID: 27064454
In the field of occupational health services, productivity loss can be expressed by absenteeism (i.e., employees being absent from work and taking leave due to health problems) and presenteeism (i.e.,...
8.
Tachi T, Teramachi H, Tanaka K, Asano S, Osawa T, Kawashima A, et al.
PLoS One
. 2015 Apr;
10(4):e0124169.
PMID: 25915539
The objective of our study was to clarify the impact of adverse events associated with the initial course of outpatient chemotherapy on the quality of life of breast cancer patients....
9.
Wu Z, Nagano I, Boonmars T, Nakada T, Takahashi Y
Appl Environ Microbiol
. 2003 Aug;
69(8):4720-6.
PMID: 12902263
A glycoprotein (Cpgp40/15)-encoding gene of Cryptosporidium parvum was analyzed to reveal intraspecies polymorphism within C. parvum isolates. Forty-one isolates were collected from different geographical origins (Japan, Italy, and Nepal) and...
10.
Nagano I, Wu Z, Nakada T, Boonmars T, Takahashi Y
J Parasitol
. 2003 Mar;
89(1):92-8.
PMID: 12659309
A serine proteinase gene was isolated from a cDNA library of Trichinella spiralis muscle larvae at 30 days post-infection (PI). The library was immunoscreened with T. spiralis-infected sera. A clone,...